Feline Medicine

The updated guidelines recommend SGLT2 inhibitors as first-line therapy for many cats with diabetes and detail patient selection, β-hydroxybutyrate monitoring, diet, and when to switch to insulin.

As companion cats continue to benefit from veterinary medical progress in disease management and live well into their “ninth life” stage, cat caretakers’ desire for veterinary hospice care may intensify.

Generic Nitenpyram Tablets become the first generic animal drug authorized under an FDA Emergency Use Authorization to treat New World screwworm myiasis in eligible dogs, cats, puppies, and kittens.

A list of available treatments for screwworm infestations in cattle, horses, sheep, goats, deer, swine, cats, dogs, exotic, zoo, and wildlife species, as well as guidance for practitioners before using these products.

The new guidelines are the American Animal Hospital Association’s first recommendations to focus on feline diabetes.

A portable gamma–optical camera brings point-of-care thyroid imaging into veterinary practice, with a new hybrid system used in Greece to evaluate cats with known or suspected hyperthyroidism.

A public health investigation documented the transmission, but risk continues to remain low.

The European Medicines Agency has recommended Nobivac NXT HCPChFelV for market authorization in the European Union.

A first-of-its-kind FDA approval for canine behavioral conditions, a potential milestone in veterinary vaccine technology, and new research complicating the picture of how H5N1 moves through dairy farm environments.

The report designates the first 12 months of a cat's life as a critical pediatric period, with implications for nutrition, vaccination timing, early sterilization, and shelter foster programs.

The new formula aims to address two common issues simultaneously.

After years of off-label use, veterinarians now have the first FDA-approved amlodipine formulation specifically indicated for cats with systemic hypertension.

Researchers have created the first large-scale genetic map of feline cancer, sequencing nearly 500 tumors across 13 cancer types and uncovering actionable mutations that could guide treatment in both cats and people.

A weekly look at the stories shaping veterinary medicine—from emerging outbreaks and policy shifts to scientific advances and industry news—all delivered in under five minutes.

New study results from Gallant show that 76% of cats improved after receiving intravenous uterine-derived mesenchymal stromal cell therapy, an immune-modulating treatment that doesn't require patient-derived cells.

In this Q&A, Tiffany Tupler, DVM, CBCC-KA, HAB, outlines a 4-part framework for addressing behavioral concerns and explains why early, proactive conversations matter.

In this Q&A, Tiffany Tupler, DVM, CBCC-KA, HABc, breaks down the feline behaviors that are most commonly misread by owners, as well as the role veterinary teams can play in setting the record straight.

The authors discuss feline behavior and how negative labels can influence patient care.

Tiffany Tupler, DVM, CBCC-KA, HAB, explains why early, proactive conversations about feline needs can help prevent both behavioral and health issues.

Tiffany Tupler, DVM, CBCC-KA, HAB, on why treating feline behavioral conditions demands the same diagnostic rigor as any other medical diagnosis—and more.

Most clients can't read their cats. Tiffany Tupler, DVM, CBCC-KA, HABc, explains why this is a clinical problem and makes the case for using clinic visits to train clients in feline communication.

Tiffany Tupler, DVM, CBCC-KA, HAB, explains how breed-related traits shape feline behavior, even when physical limitations affect a cat’s ability to act on natural instincts

Tiffany Tupler, DVM, CBCC-KA, HABc, explains why this seemingly problematic behavior is actually normal for cats—and how clear communication can help pet owners understand and manage it.

CKD in cats is often linked to aging, but a veterinarian explains how genetics, prior illness, urinary tract issues, and even geographic location may also increase risk.

The drug product from Cronus Pharma is indicated to control pain and inflammation associated with surgery in companion animals.